Navigation Links
Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer
Date:2/25/2009

s evaluated using RECIST (Response Evaluation Criteria in Solid Tumors; an internationally recognized measure of disease progression) in patients with measureable disease showed an overall response rate of 8 percent (one partial response in 13 patients with measureable disease) and a 54 percent disease control rate (six of 13 patients with measureable disease). In comparison, published literature reports overall response rates of 8 to 12 percent in patients treated with docetaxel alone.
  • These data indicate that picoplatin can be safely administered with full-dose docetaxel. Neutropenia was the main hematologic toxicity. Thrombocytopenia was less severe and less frequent with picoplatin administered in combination with docetaxel compared with picoplatin administered alone.
  • These findings confirm and extend earlier Phase 2 results presented at the 20th European Organization for Research and Treatment of Cancer - National Cancer Institute - American Association for Cancer Research (EORTC-NCI-AACR) Symposium on "Molecular Targets and Cancer" in Geneva, Switzerland, in October 2008.

    "The encouraging PSA response rates, time to PSA progression and radiologic responses rates, combined with the promising safety results observed to date, support further development of picoplatin in combination with docetaxel and prednisone in advanced prostate cancer patients," said Robert De Jager, M.D., chief medical officer of Poniard. "We continue to collect and analyze data from this trial and expect to present updated clinical data, including time to disease progression and overall survival, at medical conferences later this year."

    About Picoplatin

    Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors. Study data to date indicate that it has an improved safety profile relative to existing platinum-based cancer therapies
    '/>"/>

    SOURCE Poniard Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology technology :

    1. Poniard Pharmaceuticals to Present at the BIO CEO & Investor Conference
    2. Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
    3. Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials of Picoplatin in Colorectal and Prostate Cancers
    4. Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin
    5. Poniard Pharmaceuticals to Host Third Quarter 2008 Financial Results Conference Call on October 30
    6. Poniard Announces Positive Incremental Efficacy and Safety Data from Phase 2 Picoplatin Trial in Patients With Metastatic Colorectal Cancer
    7. Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer
    8. Poniard Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
    9. Poniard Pharmaceuticals Announces Upcoming Conference Participation
    10. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
    11. Poniard Pharmaceuticals Announces Upcoming Conference Participation
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/23/2014)... Cambridge Semantics, the leading provider of Smart ... in the recent ‘Hype Cycle for Life Sciences 2014 ... details key insights pertaining to the benefits in the ... Michael Shanler and Stephen Davies, “The use of these ... with scientific stakeholders, and support collaboration and innovation strategies ...
    (Date:9/23/2014)... 23, 2014 Dr. Williams says, “Find ... on healthcare offers a three phase process that can ... delivery system that would go far beyond anything previously ... the delivery of healthcare.” , “Every effort to improve ... to provide discernable progress throughout that system because all ...
    (Date:9/22/2014)... September 22, 2014 Pearl's Premium Ultra ... in drought tolerant grass seed this week with the ... The announcement coincides with the fact that it is ... as many believe. , As of the date ... favorable reviews by industry experts and the media including: ...
    (Date:9/22/2014)... in a mouse model of pancreatic cancer identified distinct ... including significant differences from the primary tumor that may ... their study reported in the Sept. 25 issue of ... Hospital (MGH) Cancer Center identified several different classes of ... to be targets for improved treatment of the deadly ...
    Breaking Biology Technology:Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report 2Dr. Ira Williams Offers the Healthcare Solution Necessary for Patient Safety Improvement 2Pearl's Premium Ultra Low Maintenance Lawn Seed Announces A Major Breakthrough In Drought Tolerant Grass Seed 2Massachusetts General study reveals gene expression patterns in pancreatic CTCs 2Massachusetts General study reveals gene expression patterns in pancreatic CTCs 3
    ... the World,s 3rd Largest Biotech Cluster By ... Developing more than 175 Local Companies, SAN ... 30th Anniversary Reunion for Hybritech employees will,take place on Saturday, ... Diego., In September 1978 Hybritech, San Diego,s "Granddaddy" biotech ...
    ... Inc., (TSX: IXS.V, OTC Bulletin Board: IXSBF, http://www.ixsbio.com ... of monoclonal antibodies based on its Dynamic Cross ... of Directors., Mr. Warden was a founding ... 23 years of practice, he has represented both ...
    ... Inc. (OTC Bulletin Board: CHBT) (,China-Biotics," "the,Company"), ... manufacture,research, development, marketing and distribution of probiotics ... equipment for its new manufacturing,facility., The ... is,located in Qing Pu Industrial Park (the ...
    Cached Biology Technology:San Diego's Original Biotech Company Celebrates 30th Anniversary With Reunion 2InNexus Biotechnology Strengthens Patent Team With New Leadership 2China-Biotics, Inc. Provides Update on Construction of New Manufacturing Facility 2
    (Date:9/23/2014)... soils store four times more carbon than the ... can have a big effect on atmospheric greenhouse ... Nature Climate Change concludes that climate ... or affect soil carbon storage, despite increases in ... U.S. Forest Service Research Ecologist Dr. Christian Giardina, ...
    (Date:9/23/2014)... a cyberwar against cancer finds that the immune system ... research has found that cancer is already adept at ... the interplay between cancer and the immune system to ... said Rice University,s Eshel Ben-Jacob, co-author of a new ... Proceedings of the National Academy of Sciences . ...
    (Date:9/23/2014)... is essential in the development of animals and plants. ... genetic information be translated in a reliable manner to ... The French-flag model of stripe formation is a classic ... different colours of the French flag, is caused by ... high, middle or low concentrations of the morphogen a ...
    Breaking Biology News(10 mins):Study helps assess impact of temperature on belowground soil decomposition 2Immune system is key ally in cyberwar against cancer 2Immune system is key ally in cyberwar against cancer 3Recreating the stripe patterns found in animals by engineering synthetic gene networks 2
    ... patient, according to a study recently published in PLoS ... and includes bacteria common in the environment, some of ... "This is the first reported case of invasive human ... the article. , The new bacterium ...
    ... derived human gene trees by Alan R. Templeton, Ph.D, ... major waves of human migration out of Africa instead ... 'Out of Africa' replacement theory. , That theory holds ... ago and wiped out existing populations of humans. ...
    ... that normally develops when a mouse repeatedly experiences defeat ... gene for a memory molecule in a brain circuit ... of Health's (NIH) National Institute of Mental Health (NIMH) ... molecule continued to welcome strangers in spite of repeated ...
    Cached Biology News:Scientists discover a new disease-causing bacterium in an immune-compromised patient 2New analysis shows three human migrations out of Africa 2Mice lacking social memory molecule take bullying in stride 2Mice lacking social memory molecule take bullying in stride 3